Global Molecular Pharming Supply, Demand and Key Producers, 2023-2029
The global Molecular Pharming market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Molecular pharming, also known as biopharming, is a technology that involves the use of genetically modified plants to produce pharmaceuticals or industrial chemicals. This approach relies on the ability of plants to serve as bioreactors for the production of proteins and other complex molecules.
To produce a desired protein, the gene encoding the protein is first inserted into the plant genome. The plant is then grown under controlled conditions, and the protein is harvested from the plant tissue. The protein can then be purified and used for a variety of applications, including drug development, vaccines, and enzyme replacement therapies.
Molecular pharming has several advantages over traditional methods of protein production. Plants are relatively easy to grow and require minimal processing, which can result in lower production costs. Additionally, plant-based production systems are considered to be safer than those that use animal cells or bacteria, as plants are less likely to transmit viruses or other contaminants.
Despite its potential benefits, molecular pharming also has some limitations and challenges. One of the main challenges is ensuring that the plant-produced proteins are properly folded and functional, which can be influenced by factors such as post-translational modifications, environmental conditions, and the choice of plant species. Additionally, there are regulatory and ethical considerations associated with using genetically modified plants for pharmaceutical production.
This report studies the global Molecular Pharming demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Molecular Pharming, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Molecular Pharming that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Molecular Pharming total market, 2018-2029, (USD Million)
Global Molecular Pharming total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Molecular Pharming total market, key domestic companies and share, (USD Million)
Global Molecular Pharming revenue by player and market share 2018-2023, (USD Million)
Global Molecular Pharming total market by Type, CAGR, 2018-2029, (USD Million)
Global Molecular Pharming total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Molecular Pharming market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medicago Inc, Meristem Therapeutics S.A. (Ventria Bioscience), Miruku, Moolec Science Limited, mozza, Nobell Foods, Agrenvec S.L, Bright Biotech and Core Biogenesis, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Molecular Pharming market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Molecular Pharming Market, By Region:
1. How big is the global Molecular Pharming market?
2. What is the demand of the global Molecular Pharming market?
3. What is the year over year growth of the global Molecular Pharming market?
4. What is the total value of the global Molecular Pharming market?
5. Who are the major players in the global Molecular Pharming market?
6. What are the growth factors driving the market demand?
Molecular pharming, also known as biopharming, is a technology that involves the use of genetically modified plants to produce pharmaceuticals or industrial chemicals. This approach relies on the ability of plants to serve as bioreactors for the production of proteins and other complex molecules.
To produce a desired protein, the gene encoding the protein is first inserted into the plant genome. The plant is then grown under controlled conditions, and the protein is harvested from the plant tissue. The protein can then be purified and used for a variety of applications, including drug development, vaccines, and enzyme replacement therapies.
Molecular pharming has several advantages over traditional methods of protein production. Plants are relatively easy to grow and require minimal processing, which can result in lower production costs. Additionally, plant-based production systems are considered to be safer than those that use animal cells or bacteria, as plants are less likely to transmit viruses or other contaminants.
Despite its potential benefits, molecular pharming also has some limitations and challenges. One of the main challenges is ensuring that the plant-produced proteins are properly folded and functional, which can be influenced by factors such as post-translational modifications, environmental conditions, and the choice of plant species. Additionally, there are regulatory and ethical considerations associated with using genetically modified plants for pharmaceutical production.
This report studies the global Molecular Pharming demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Molecular Pharming, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Molecular Pharming that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Molecular Pharming total market, 2018-2029, (USD Million)
Global Molecular Pharming total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Molecular Pharming total market, key domestic companies and share, (USD Million)
Global Molecular Pharming revenue by player and market share 2018-2023, (USD Million)
Global Molecular Pharming total market by Type, CAGR, 2018-2029, (USD Million)
Global Molecular Pharming total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Molecular Pharming market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medicago Inc, Meristem Therapeutics S.A. (Ventria Bioscience), Miruku, Moolec Science Limited, mozza, Nobell Foods, Agrenvec S.L, Bright Biotech and Core Biogenesis, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Molecular Pharming market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Molecular Pharming Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Gene Gun
- Agroinfiltration
- Electroporation
- Agrobacterium-Mediated Gene Transfer
- Recombinant Antibodies
- Hormones, Vaccines
- Industrial Enzymes
- Proteins & Protein-Based Materials
- Technical Reagents
- Nutritional Products
- Medicago Inc
- Meristem Therapeutics S.A. (Ventria Bioscience)
- Miruku
- Moolec Science Limited
- mozza
- Nobell Foods
- Agrenvec S.L
- Bright Biotech
- Core Biogenesis
- Diamante SRL
- Leaf Systems International Limited
- ORF Genetics
- Pfizer, Inc.
- ProdiGene Inc
- Protalix Biotherapeutics, Inc
- Tiamat Sciences
1. How big is the global Molecular Pharming market?
2. What is the demand of the global Molecular Pharming market?
3. What is the year over year growth of the global Molecular Pharming market?
4. What is the total value of the global Molecular Pharming market?
5. Who are the major players in the global Molecular Pharming market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Molecular Pharming Introduction
1.2 World Molecular Pharming Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Molecular Pharming Total Market by Region (by Headquarter Location)
1.3.1 World Molecular Pharming Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Molecular Pharming Market Size (2018-2029)
1.3.3 China Molecular Pharming Market Size (2018-2029)
1.3.4 Europe Molecular Pharming Market Size (2018-2029)
1.3.5 Japan Molecular Pharming Market Size (2018-2029)
1.3.6 South Korea Molecular Pharming Market Size (2018-2029)
1.3.7 ASEAN Molecular Pharming Market Size (2018-2029)
1.3.8 India Molecular Pharming Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Molecular Pharming Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Molecular Pharming Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Molecular Pharming Consumption Value (2018-2029)
2.2 World Molecular Pharming Consumption Value by Region
2.2.1 World Molecular Pharming Consumption Value by Region (2018-2023)
2.2.2 World Molecular Pharming Consumption Value Forecast by Region (2024-2029)
2.3 United States Molecular Pharming Consumption Value (2018-2029)
2.4 China Molecular Pharming Consumption Value (2018-2029)
2.5 Europe Molecular Pharming Consumption Value (2018-2029)
2.6 Japan Molecular Pharming Consumption Value (2018-2029)
2.7 South Korea Molecular Pharming Consumption Value (2018-2029)
2.8 ASEAN Molecular Pharming Consumption Value (2018-2029)
2.9 India Molecular Pharming Consumption Value (2018-2029)
3 WORLD MOLECULAR PHARMING COMPANIES COMPETITIVE ANALYSIS
3.1 World Molecular Pharming Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Molecular Pharming Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Molecular Pharming in 2022
3.2.3 Global Concentration Ratios (CR8) for Molecular Pharming in 2022
3.3 Molecular Pharming Company Evaluation Quadrant
3.4 Molecular Pharming Market: Overall Company Footprint Analysis
3.4.1 Molecular Pharming Market: Region Footprint
3.4.2 Molecular Pharming Market: Company Product Type Footprint
3.4.3 Molecular Pharming Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Molecular Pharming Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Molecular Pharming Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Molecular Pharming Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Molecular Pharming Consumption Value Comparison
4.2.1 United States VS China: Molecular Pharming Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Molecular Pharming Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Molecular Pharming Companies and Market Share, 2018-2023
4.3.1 United States Based Molecular Pharming Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Molecular Pharming Revenue, (2018-2023)
4.4 China Based Companies Molecular Pharming Revenue and Market Share, 2018-2023
4.4.1 China Based Molecular Pharming Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Molecular Pharming Revenue, (2018-2023)
4.5 Rest of World Based Molecular Pharming Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Molecular Pharming Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Molecular Pharming Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Molecular Pharming Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Gene Gun
5.2.2 Agroinfiltration
5.2.3 Electroporation
5.2.4 Agrobacterium-Mediated Gene Transfer
5.3 Market Segment by Type
5.3.1 World Molecular Pharming Market Size by Type (2018-2023)
5.3.2 World Molecular Pharming Market Size by Type (2024-2029)
5.3.3 World Molecular Pharming Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Molecular Pharming Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Recombinant Antibodies
6.2.2 Hormones, Vaccines
6.2.3 Industrial Enzymes
6.2.4 Proteins & Protein-Based Materials
6.2.5 Proteins & Protein-Based Materials
6.2.6 Nutritional Products
6.3 Market Segment by Application
6.3.1 World Molecular Pharming Market Size by Application (2018-2023)
6.3.2 World Molecular Pharming Market Size by Application (2024-2029)
6.3.3 World Molecular Pharming Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Medicago Inc
7.1.1 Medicago Inc Details
7.1.2 Medicago Inc Major Business
7.1.3 Medicago Inc Molecular Pharming Product and Services
7.1.4 Medicago Inc Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Medicago Inc Recent Developments/Updates
7.1.6 Medicago Inc Competitive Strengths & Weaknesses
7.2 Meristem Therapeutics S.A. (Ventria Bioscience)
7.2.1 Meristem Therapeutics S.A. (Ventria Bioscience) Details
7.2.2 Meristem Therapeutics S.A. (Ventria Bioscience) Major Business
7.2.3 Meristem Therapeutics S.A. (Ventria Bioscience) Molecular Pharming Product and Services
7.2.4 Meristem Therapeutics S.A. (Ventria Bioscience) Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Meristem Therapeutics S.A. (Ventria Bioscience) Recent Developments/Updates
7.2.6 Meristem Therapeutics S.A. (Ventria Bioscience) Competitive Strengths & Weaknesses
7.3 Miruku
7.3.1 Miruku Details
7.3.2 Miruku Major Business
7.3.3 Miruku Molecular Pharming Product and Services
7.3.4 Miruku Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Miruku Recent Developments/Updates
7.3.6 Miruku Competitive Strengths & Weaknesses
7.4 Moolec Science Limited
7.4.1 Moolec Science Limited Details
7.4.2 Moolec Science Limited Major Business
7.4.3 Moolec Science Limited Molecular Pharming Product and Services
7.4.4 Moolec Science Limited Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Moolec Science Limited Recent Developments/Updates
7.4.6 Moolec Science Limited Competitive Strengths & Weaknesses
7.5 mozza
7.5.1 mozza Details
7.5.2 mozza Major Business
7.5.3 mozza Molecular Pharming Product and Services
7.5.4 mozza Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 mozza Recent Developments/Updates
7.5.6 mozza Competitive Strengths & Weaknesses
7.6 Nobell Foods
7.6.1 Nobell Foods Details
7.6.2 Nobell Foods Major Business
7.6.3 Nobell Foods Molecular Pharming Product and Services
7.6.4 Nobell Foods Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Nobell Foods Recent Developments/Updates
7.6.6 Nobell Foods Competitive Strengths & Weaknesses
7.7 Agrenvec S.L
7.7.1 Agrenvec S.L Details
7.7.2 Agrenvec S.L Major Business
7.7.3 Agrenvec S.L Molecular Pharming Product and Services
7.7.4 Agrenvec S.L Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Agrenvec S.L Recent Developments/Updates
7.7.6 Agrenvec S.L Competitive Strengths & Weaknesses
7.8 Bright Biotech
7.8.1 Bright Biotech Details
7.8.2 Bright Biotech Major Business
7.8.3 Bright Biotech Molecular Pharming Product and Services
7.8.4 Bright Biotech Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Bright Biotech Recent Developments/Updates
7.8.6 Bright Biotech Competitive Strengths & Weaknesses
7.9 Core Biogenesis
7.9.1 Core Biogenesis Details
7.9.2 Core Biogenesis Major Business
7.9.3 Core Biogenesis Molecular Pharming Product and Services
7.9.4 Core Biogenesis Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Core Biogenesis Recent Developments/Updates
7.9.6 Core Biogenesis Competitive Strengths & Weaknesses
7.10 Diamante SRL
7.10.1 Diamante SRL Details
7.10.2 Diamante SRL Major Business
7.10.3 Diamante SRL Molecular Pharming Product and Services
7.10.4 Diamante SRL Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Diamante SRL Recent Developments/Updates
7.10.6 Diamante SRL Competitive Strengths & Weaknesses
7.11 Leaf Systems International Limited
7.11.1 Leaf Systems International Limited Details
7.11.2 Leaf Systems International Limited Major Business
7.11.3 Leaf Systems International Limited Molecular Pharming Product and Services
7.11.4 Leaf Systems International Limited Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Leaf Systems International Limited Recent Developments/Updates
7.11.6 Leaf Systems International Limited Competitive Strengths & Weaknesses
7.12 ORF Genetics
7.12.1 ORF Genetics Details
7.12.2 ORF Genetics Major Business
7.12.3 ORF Genetics Molecular Pharming Product and Services
7.12.4 ORF Genetics Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 ORF Genetics Recent Developments/Updates
7.12.6 ORF Genetics Competitive Strengths & Weaknesses
7.13 Pfizer, Inc.
7.13.1 Pfizer, Inc. Details
7.13.2 Pfizer, Inc. Major Business
7.13.3 Pfizer, Inc. Molecular Pharming Product and Services
7.13.4 Pfizer, Inc. Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Pfizer, Inc. Recent Developments/Updates
7.13.6 Pfizer, Inc. Competitive Strengths & Weaknesses
7.14 ProdiGene Inc
7.14.1 ProdiGene Inc Details
7.14.2 ProdiGene Inc Major Business
7.14.3 ProdiGene Inc Molecular Pharming Product and Services
7.14.4 ProdiGene Inc Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 ProdiGene Inc Recent Developments/Updates
7.14.6 ProdiGene Inc Competitive Strengths & Weaknesses
7.15 Protalix Biotherapeutics, Inc
7.15.1 Protalix Biotherapeutics, Inc Details
7.15.2 Protalix Biotherapeutics, Inc Major Business
7.15.3 Protalix Biotherapeutics, Inc Molecular Pharming Product and Services
7.15.4 Protalix Biotherapeutics, Inc Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Protalix Biotherapeutics, Inc Recent Developments/Updates
7.15.6 Protalix Biotherapeutics, Inc Competitive Strengths & Weaknesses
7.16 Tiamat Sciences
7.16.1 Tiamat Sciences Details
7.16.2 Tiamat Sciences Major Business
7.16.3 Tiamat Sciences Molecular Pharming Product and Services
7.16.4 Tiamat Sciences Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Tiamat Sciences Recent Developments/Updates
7.16.6 Tiamat Sciences Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Molecular Pharming Industry Chain
8.2 Molecular Pharming Upstream Analysis
8.3 Molecular Pharming Midstream Analysis
8.4 Molecular Pharming Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Molecular Pharming Introduction
1.2 World Molecular Pharming Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Molecular Pharming Total Market by Region (by Headquarter Location)
1.3.1 World Molecular Pharming Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Molecular Pharming Market Size (2018-2029)
1.3.3 China Molecular Pharming Market Size (2018-2029)
1.3.4 Europe Molecular Pharming Market Size (2018-2029)
1.3.5 Japan Molecular Pharming Market Size (2018-2029)
1.3.6 South Korea Molecular Pharming Market Size (2018-2029)
1.3.7 ASEAN Molecular Pharming Market Size (2018-2029)
1.3.8 India Molecular Pharming Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Molecular Pharming Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Molecular Pharming Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Molecular Pharming Consumption Value (2018-2029)
2.2 World Molecular Pharming Consumption Value by Region
2.2.1 World Molecular Pharming Consumption Value by Region (2018-2023)
2.2.2 World Molecular Pharming Consumption Value Forecast by Region (2024-2029)
2.3 United States Molecular Pharming Consumption Value (2018-2029)
2.4 China Molecular Pharming Consumption Value (2018-2029)
2.5 Europe Molecular Pharming Consumption Value (2018-2029)
2.6 Japan Molecular Pharming Consumption Value (2018-2029)
2.7 South Korea Molecular Pharming Consumption Value (2018-2029)
2.8 ASEAN Molecular Pharming Consumption Value (2018-2029)
2.9 India Molecular Pharming Consumption Value (2018-2029)
3 WORLD MOLECULAR PHARMING COMPANIES COMPETITIVE ANALYSIS
3.1 World Molecular Pharming Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Molecular Pharming Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Molecular Pharming in 2022
3.2.3 Global Concentration Ratios (CR8) for Molecular Pharming in 2022
3.3 Molecular Pharming Company Evaluation Quadrant
3.4 Molecular Pharming Market: Overall Company Footprint Analysis
3.4.1 Molecular Pharming Market: Region Footprint
3.4.2 Molecular Pharming Market: Company Product Type Footprint
3.4.3 Molecular Pharming Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Molecular Pharming Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Molecular Pharming Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Molecular Pharming Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Molecular Pharming Consumption Value Comparison
4.2.1 United States VS China: Molecular Pharming Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Molecular Pharming Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Molecular Pharming Companies and Market Share, 2018-2023
4.3.1 United States Based Molecular Pharming Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Molecular Pharming Revenue, (2018-2023)
4.4 China Based Companies Molecular Pharming Revenue and Market Share, 2018-2023
4.4.1 China Based Molecular Pharming Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Molecular Pharming Revenue, (2018-2023)
4.5 Rest of World Based Molecular Pharming Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Molecular Pharming Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Molecular Pharming Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Molecular Pharming Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Gene Gun
5.2.2 Agroinfiltration
5.2.3 Electroporation
5.2.4 Agrobacterium-Mediated Gene Transfer
5.3 Market Segment by Type
5.3.1 World Molecular Pharming Market Size by Type (2018-2023)
5.3.2 World Molecular Pharming Market Size by Type (2024-2029)
5.3.3 World Molecular Pharming Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Molecular Pharming Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Recombinant Antibodies
6.2.2 Hormones, Vaccines
6.2.3 Industrial Enzymes
6.2.4 Proteins & Protein-Based Materials
6.2.5 Proteins & Protein-Based Materials
6.2.6 Nutritional Products
6.3 Market Segment by Application
6.3.1 World Molecular Pharming Market Size by Application (2018-2023)
6.3.2 World Molecular Pharming Market Size by Application (2024-2029)
6.3.3 World Molecular Pharming Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Medicago Inc
7.1.1 Medicago Inc Details
7.1.2 Medicago Inc Major Business
7.1.3 Medicago Inc Molecular Pharming Product and Services
7.1.4 Medicago Inc Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Medicago Inc Recent Developments/Updates
7.1.6 Medicago Inc Competitive Strengths & Weaknesses
7.2 Meristem Therapeutics S.A. (Ventria Bioscience)
7.2.1 Meristem Therapeutics S.A. (Ventria Bioscience) Details
7.2.2 Meristem Therapeutics S.A. (Ventria Bioscience) Major Business
7.2.3 Meristem Therapeutics S.A. (Ventria Bioscience) Molecular Pharming Product and Services
7.2.4 Meristem Therapeutics S.A. (Ventria Bioscience) Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Meristem Therapeutics S.A. (Ventria Bioscience) Recent Developments/Updates
7.2.6 Meristem Therapeutics S.A. (Ventria Bioscience) Competitive Strengths & Weaknesses
7.3 Miruku
7.3.1 Miruku Details
7.3.2 Miruku Major Business
7.3.3 Miruku Molecular Pharming Product and Services
7.3.4 Miruku Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Miruku Recent Developments/Updates
7.3.6 Miruku Competitive Strengths & Weaknesses
7.4 Moolec Science Limited
7.4.1 Moolec Science Limited Details
7.4.2 Moolec Science Limited Major Business
7.4.3 Moolec Science Limited Molecular Pharming Product and Services
7.4.4 Moolec Science Limited Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Moolec Science Limited Recent Developments/Updates
7.4.6 Moolec Science Limited Competitive Strengths & Weaknesses
7.5 mozza
7.5.1 mozza Details
7.5.2 mozza Major Business
7.5.3 mozza Molecular Pharming Product and Services
7.5.4 mozza Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 mozza Recent Developments/Updates
7.5.6 mozza Competitive Strengths & Weaknesses
7.6 Nobell Foods
7.6.1 Nobell Foods Details
7.6.2 Nobell Foods Major Business
7.6.3 Nobell Foods Molecular Pharming Product and Services
7.6.4 Nobell Foods Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Nobell Foods Recent Developments/Updates
7.6.6 Nobell Foods Competitive Strengths & Weaknesses
7.7 Agrenvec S.L
7.7.1 Agrenvec S.L Details
7.7.2 Agrenvec S.L Major Business
7.7.3 Agrenvec S.L Molecular Pharming Product and Services
7.7.4 Agrenvec S.L Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Agrenvec S.L Recent Developments/Updates
7.7.6 Agrenvec S.L Competitive Strengths & Weaknesses
7.8 Bright Biotech
7.8.1 Bright Biotech Details
7.8.2 Bright Biotech Major Business
7.8.3 Bright Biotech Molecular Pharming Product and Services
7.8.4 Bright Biotech Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Bright Biotech Recent Developments/Updates
7.8.6 Bright Biotech Competitive Strengths & Weaknesses
7.9 Core Biogenesis
7.9.1 Core Biogenesis Details
7.9.2 Core Biogenesis Major Business
7.9.3 Core Biogenesis Molecular Pharming Product and Services
7.9.4 Core Biogenesis Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Core Biogenesis Recent Developments/Updates
7.9.6 Core Biogenesis Competitive Strengths & Weaknesses
7.10 Diamante SRL
7.10.1 Diamante SRL Details
7.10.2 Diamante SRL Major Business
7.10.3 Diamante SRL Molecular Pharming Product and Services
7.10.4 Diamante SRL Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Diamante SRL Recent Developments/Updates
7.10.6 Diamante SRL Competitive Strengths & Weaknesses
7.11 Leaf Systems International Limited
7.11.1 Leaf Systems International Limited Details
7.11.2 Leaf Systems International Limited Major Business
7.11.3 Leaf Systems International Limited Molecular Pharming Product and Services
7.11.4 Leaf Systems International Limited Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Leaf Systems International Limited Recent Developments/Updates
7.11.6 Leaf Systems International Limited Competitive Strengths & Weaknesses
7.12 ORF Genetics
7.12.1 ORF Genetics Details
7.12.2 ORF Genetics Major Business
7.12.3 ORF Genetics Molecular Pharming Product and Services
7.12.4 ORF Genetics Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 ORF Genetics Recent Developments/Updates
7.12.6 ORF Genetics Competitive Strengths & Weaknesses
7.13 Pfizer, Inc.
7.13.1 Pfizer, Inc. Details
7.13.2 Pfizer, Inc. Major Business
7.13.3 Pfizer, Inc. Molecular Pharming Product and Services
7.13.4 Pfizer, Inc. Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Pfizer, Inc. Recent Developments/Updates
7.13.6 Pfizer, Inc. Competitive Strengths & Weaknesses
7.14 ProdiGene Inc
7.14.1 ProdiGene Inc Details
7.14.2 ProdiGene Inc Major Business
7.14.3 ProdiGene Inc Molecular Pharming Product and Services
7.14.4 ProdiGene Inc Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 ProdiGene Inc Recent Developments/Updates
7.14.6 ProdiGene Inc Competitive Strengths & Weaknesses
7.15 Protalix Biotherapeutics, Inc
7.15.1 Protalix Biotherapeutics, Inc Details
7.15.2 Protalix Biotherapeutics, Inc Major Business
7.15.3 Protalix Biotherapeutics, Inc Molecular Pharming Product and Services
7.15.4 Protalix Biotherapeutics, Inc Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Protalix Biotherapeutics, Inc Recent Developments/Updates
7.15.6 Protalix Biotherapeutics, Inc Competitive Strengths & Weaknesses
7.16 Tiamat Sciences
7.16.1 Tiamat Sciences Details
7.16.2 Tiamat Sciences Major Business
7.16.3 Tiamat Sciences Molecular Pharming Product and Services
7.16.4 Tiamat Sciences Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Tiamat Sciences Recent Developments/Updates
7.16.6 Tiamat Sciences Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Molecular Pharming Industry Chain
8.2 Molecular Pharming Upstream Analysis
8.3 Molecular Pharming Midstream Analysis
8.4 Molecular Pharming Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Molecular Pharming Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Molecular Pharming Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Molecular Pharming Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Molecular Pharming Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Molecular Pharming Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Molecular Pharming Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Molecular Pharming Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Molecular Pharming Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Molecular Pharming Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Molecular Pharming Players in 2022
Table 12. World Molecular Pharming Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Molecular Pharming Company Evaluation Quadrant
Table 14. Head Office of Key Molecular Pharming Player
Table 15. Molecular Pharming Market: Company Product Type Footprint
Table 16. Molecular Pharming Market: Company Product Application Footprint
Table 17. Molecular Pharming Mergers & Acquisitions Activity
Table 18. United States VS China Molecular Pharming Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Molecular Pharming Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Molecular Pharming Companies, Headquarters (States, Country)
Table 21. United States Based Companies Molecular Pharming Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Molecular Pharming Revenue Market Share (2018-2023)
Table 23. China Based Molecular Pharming Companies, Headquarters (Province, Country)
Table 24. China Based Companies Molecular Pharming Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Molecular Pharming Revenue Market Share (2018-2023)
Table 26. Rest of World Based Molecular Pharming Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Molecular Pharming Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Molecular Pharming Revenue Market Share (2018-2023)
Table 29. World Molecular Pharming Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Molecular Pharming Market Size by Type (2018-2023) & (USD Million)
Table 31. World Molecular Pharming Market Size by Type (2024-2029) & (USD Million)
Table 32. World Molecular Pharming Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Molecular Pharming Market Size by Application (2018-2023) & (USD Million)
Table 34. World Molecular Pharming Market Size by Application (2024-2029) & (USD Million)
Table 35. Medicago Inc Basic Information, Area Served and Competitors
Table 36. Medicago Inc Major Business
Table 37. Medicago Inc Molecular Pharming Product and Services
Table 38. Medicago Inc Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Medicago Inc Recent Developments/Updates
Table 40. Medicago Inc Competitive Strengths & Weaknesses
Table 41. Meristem Therapeutics S.A. (Ventria Bioscience) Basic Information, Area Served and Competitors
Table 42. Meristem Therapeutics S.A. (Ventria Bioscience) Major Business
Table 43. Meristem Therapeutics S.A. (Ventria Bioscience) Molecular Pharming Product and Services
Table 44. Meristem Therapeutics S.A. (Ventria Bioscience) Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Meristem Therapeutics S.A. (Ventria Bioscience) Recent Developments/Updates
Table 46. Meristem Therapeutics S.A. (Ventria Bioscience) Competitive Strengths & Weaknesses
Table 47. Miruku Basic Information, Area Served and Competitors
Table 48. Miruku Major Business
Table 49. Miruku Molecular Pharming Product and Services
Table 50. Miruku Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Miruku Recent Developments/Updates
Table 52. Miruku Competitive Strengths & Weaknesses
Table 53. Moolec Science Limited Basic Information, Area Served and Competitors
Table 54. Moolec Science Limited Major Business
Table 55. Moolec Science Limited Molecular Pharming Product and Services
Table 56. Moolec Science Limited Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Moolec Science Limited Recent Developments/Updates
Table 58. Moolec Science Limited Competitive Strengths & Weaknesses
Table 59. mozza Basic Information, Area Served and Competitors
Table 60. mozza Major Business
Table 61. mozza Molecular Pharming Product and Services
Table 62. mozza Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. mozza Recent Developments/Updates
Table 64. mozza Competitive Strengths & Weaknesses
Table 65. Nobell Foods Basic Information, Area Served and Competitors
Table 66. Nobell Foods Major Business
Table 67. Nobell Foods Molecular Pharming Product and Services
Table 68. Nobell Foods Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Nobell Foods Recent Developments/Updates
Table 70. Nobell Foods Competitive Strengths & Weaknesses
Table 71. Agrenvec S.L Basic Information, Area Served and Competitors
Table 72. Agrenvec S.L Major Business
Table 73. Agrenvec S.L Molecular Pharming Product and Services
Table 74. Agrenvec S.L Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Agrenvec S.L Recent Developments/Updates
Table 76. Agrenvec S.L Competitive Strengths & Weaknesses
Table 77. Bright Biotech Basic Information, Area Served and Competitors
Table 78. Bright Biotech Major Business
Table 79. Bright Biotech Molecular Pharming Product and Services
Table 80. Bright Biotech Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Bright Biotech Recent Developments/Updates
Table 82. Bright Biotech Competitive Strengths & Weaknesses
Table 83. Core Biogenesis Basic Information, Area Served and Competitors
Table 84. Core Biogenesis Major Business
Table 85. Core Biogenesis Molecular Pharming Product and Services
Table 86. Core Biogenesis Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Core Biogenesis Recent Developments/Updates
Table 88. Core Biogenesis Competitive Strengths & Weaknesses
Table 89. Diamante SRL Basic Information, Area Served and Competitors
Table 90. Diamante SRL Major Business
Table 91. Diamante SRL Molecular Pharming Product and Services
Table 92. Diamante SRL Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Diamante SRL Recent Developments/Updates
Table 94. Diamante SRL Competitive Strengths & Weaknesses
Table 95. Leaf Systems International Limited Basic Information, Area Served and Competitors
Table 96. Leaf Systems International Limited Major Business
Table 97. Leaf Systems International Limited Molecular Pharming Product and Services
Table 98. Leaf Systems International Limited Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Leaf Systems International Limited Recent Developments/Updates
Table 100. Leaf Systems International Limited Competitive Strengths & Weaknesses
Table 101. ORF Genetics Basic Information, Area Served and Competitors
Table 102. ORF Genetics Major Business
Table 103. ORF Genetics Molecular Pharming Product and Services
Table 104. ORF Genetics Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. ORF Genetics Recent Developments/Updates
Table 106. ORF Genetics Competitive Strengths & Weaknesses
Table 107. Pfizer, Inc. Basic Information, Area Served and Competitors
Table 108. Pfizer, Inc. Major Business
Table 109. Pfizer, Inc. Molecular Pharming Product and Services
Table 110. Pfizer, Inc. Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Pfizer, Inc. Recent Developments/Updates
Table 112. Pfizer, Inc. Competitive Strengths & Weaknesses
Table 113. ProdiGene Inc Basic Information, Area Served and Competitors
Table 114. ProdiGene Inc Major Business
Table 115. ProdiGene Inc Molecular Pharming Product and Services
Table 116. ProdiGene Inc Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. ProdiGene Inc Recent Developments/Updates
Table 118. ProdiGene Inc Competitive Strengths & Weaknesses
Table 119. Protalix Biotherapeutics, Inc Basic Information, Area Served and Competitors
Table 120. Protalix Biotherapeutics, Inc Major Business
Table 121. Protalix Biotherapeutics, Inc Molecular Pharming Product and Services
Table 122. Protalix Biotherapeutics, Inc Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Protalix Biotherapeutics, Inc Recent Developments/Updates
Table 124. Tiamat Sciences Basic Information, Area Served and Competitors
Table 125. Tiamat Sciences Major Business
Table 126. Tiamat Sciences Molecular Pharming Product and Services
Table 127. Tiamat Sciences Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 128. Global Key Players of Molecular Pharming Upstream (Raw Materials)
Table 129. Molecular Pharming Typical Customers
Table 1. World Molecular Pharming Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Molecular Pharming Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Molecular Pharming Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Molecular Pharming Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Molecular Pharming Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Molecular Pharming Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Molecular Pharming Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Molecular Pharming Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Molecular Pharming Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Molecular Pharming Players in 2022
Table 12. World Molecular Pharming Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Molecular Pharming Company Evaluation Quadrant
Table 14. Head Office of Key Molecular Pharming Player
Table 15. Molecular Pharming Market: Company Product Type Footprint
Table 16. Molecular Pharming Market: Company Product Application Footprint
Table 17. Molecular Pharming Mergers & Acquisitions Activity
Table 18. United States VS China Molecular Pharming Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Molecular Pharming Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Molecular Pharming Companies, Headquarters (States, Country)
Table 21. United States Based Companies Molecular Pharming Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Molecular Pharming Revenue Market Share (2018-2023)
Table 23. China Based Molecular Pharming Companies, Headquarters (Province, Country)
Table 24. China Based Companies Molecular Pharming Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Molecular Pharming Revenue Market Share (2018-2023)
Table 26. Rest of World Based Molecular Pharming Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Molecular Pharming Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Molecular Pharming Revenue Market Share (2018-2023)
Table 29. World Molecular Pharming Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Molecular Pharming Market Size by Type (2018-2023) & (USD Million)
Table 31. World Molecular Pharming Market Size by Type (2024-2029) & (USD Million)
Table 32. World Molecular Pharming Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Molecular Pharming Market Size by Application (2018-2023) & (USD Million)
Table 34. World Molecular Pharming Market Size by Application (2024-2029) & (USD Million)
Table 35. Medicago Inc Basic Information, Area Served and Competitors
Table 36. Medicago Inc Major Business
Table 37. Medicago Inc Molecular Pharming Product and Services
Table 38. Medicago Inc Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Medicago Inc Recent Developments/Updates
Table 40. Medicago Inc Competitive Strengths & Weaknesses
Table 41. Meristem Therapeutics S.A. (Ventria Bioscience) Basic Information, Area Served and Competitors
Table 42. Meristem Therapeutics S.A. (Ventria Bioscience) Major Business
Table 43. Meristem Therapeutics S.A. (Ventria Bioscience) Molecular Pharming Product and Services
Table 44. Meristem Therapeutics S.A. (Ventria Bioscience) Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Meristem Therapeutics S.A. (Ventria Bioscience) Recent Developments/Updates
Table 46. Meristem Therapeutics S.A. (Ventria Bioscience) Competitive Strengths & Weaknesses
Table 47. Miruku Basic Information, Area Served and Competitors
Table 48. Miruku Major Business
Table 49. Miruku Molecular Pharming Product and Services
Table 50. Miruku Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Miruku Recent Developments/Updates
Table 52. Miruku Competitive Strengths & Weaknesses
Table 53. Moolec Science Limited Basic Information, Area Served and Competitors
Table 54. Moolec Science Limited Major Business
Table 55. Moolec Science Limited Molecular Pharming Product and Services
Table 56. Moolec Science Limited Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Moolec Science Limited Recent Developments/Updates
Table 58. Moolec Science Limited Competitive Strengths & Weaknesses
Table 59. mozza Basic Information, Area Served and Competitors
Table 60. mozza Major Business
Table 61. mozza Molecular Pharming Product and Services
Table 62. mozza Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. mozza Recent Developments/Updates
Table 64. mozza Competitive Strengths & Weaknesses
Table 65. Nobell Foods Basic Information, Area Served and Competitors
Table 66. Nobell Foods Major Business
Table 67. Nobell Foods Molecular Pharming Product and Services
Table 68. Nobell Foods Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Nobell Foods Recent Developments/Updates
Table 70. Nobell Foods Competitive Strengths & Weaknesses
Table 71. Agrenvec S.L Basic Information, Area Served and Competitors
Table 72. Agrenvec S.L Major Business
Table 73. Agrenvec S.L Molecular Pharming Product and Services
Table 74. Agrenvec S.L Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Agrenvec S.L Recent Developments/Updates
Table 76. Agrenvec S.L Competitive Strengths & Weaknesses
Table 77. Bright Biotech Basic Information, Area Served and Competitors
Table 78. Bright Biotech Major Business
Table 79. Bright Biotech Molecular Pharming Product and Services
Table 80. Bright Biotech Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Bright Biotech Recent Developments/Updates
Table 82. Bright Biotech Competitive Strengths & Weaknesses
Table 83. Core Biogenesis Basic Information, Area Served and Competitors
Table 84. Core Biogenesis Major Business
Table 85. Core Biogenesis Molecular Pharming Product and Services
Table 86. Core Biogenesis Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Core Biogenesis Recent Developments/Updates
Table 88. Core Biogenesis Competitive Strengths & Weaknesses
Table 89. Diamante SRL Basic Information, Area Served and Competitors
Table 90. Diamante SRL Major Business
Table 91. Diamante SRL Molecular Pharming Product and Services
Table 92. Diamante SRL Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Diamante SRL Recent Developments/Updates
Table 94. Diamante SRL Competitive Strengths & Weaknesses
Table 95. Leaf Systems International Limited Basic Information, Area Served and Competitors
Table 96. Leaf Systems International Limited Major Business
Table 97. Leaf Systems International Limited Molecular Pharming Product and Services
Table 98. Leaf Systems International Limited Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Leaf Systems International Limited Recent Developments/Updates
Table 100. Leaf Systems International Limited Competitive Strengths & Weaknesses
Table 101. ORF Genetics Basic Information, Area Served and Competitors
Table 102. ORF Genetics Major Business
Table 103. ORF Genetics Molecular Pharming Product and Services
Table 104. ORF Genetics Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. ORF Genetics Recent Developments/Updates
Table 106. ORF Genetics Competitive Strengths & Weaknesses
Table 107. Pfizer, Inc. Basic Information, Area Served and Competitors
Table 108. Pfizer, Inc. Major Business
Table 109. Pfizer, Inc. Molecular Pharming Product and Services
Table 110. Pfizer, Inc. Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Pfizer, Inc. Recent Developments/Updates
Table 112. Pfizer, Inc. Competitive Strengths & Weaknesses
Table 113. ProdiGene Inc Basic Information, Area Served and Competitors
Table 114. ProdiGene Inc Major Business
Table 115. ProdiGene Inc Molecular Pharming Product and Services
Table 116. ProdiGene Inc Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. ProdiGene Inc Recent Developments/Updates
Table 118. ProdiGene Inc Competitive Strengths & Weaknesses
Table 119. Protalix Biotherapeutics, Inc Basic Information, Area Served and Competitors
Table 120. Protalix Biotherapeutics, Inc Major Business
Table 121. Protalix Biotherapeutics, Inc Molecular Pharming Product and Services
Table 122. Protalix Biotherapeutics, Inc Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Protalix Biotherapeutics, Inc Recent Developments/Updates
Table 124. Tiamat Sciences Basic Information, Area Served and Competitors
Table 125. Tiamat Sciences Major Business
Table 126. Tiamat Sciences Molecular Pharming Product and Services
Table 127. Tiamat Sciences Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 128. Global Key Players of Molecular Pharming Upstream (Raw Materials)
Table 129. Molecular Pharming Typical Customers
LIST OF FIGURES
Figure 1. Molecular Pharming Picture
Figure 2. World Molecular Pharming Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Molecular Pharming Total Market Size (2018-2029) & (USD Million)
Figure 4. World Molecular Pharming Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Molecular Pharming Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Molecular Pharming Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Molecular Pharming Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Molecular Pharming Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Molecular Pharming Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Molecular Pharming Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Molecular Pharming Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Molecular Pharming Revenue (2018-2029) & (USD Million)
Figure 13. Molecular Pharming Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Molecular Pharming Consumption Value (2018-2029) & (USD Million)
Figure 16. World Molecular Pharming Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Molecular Pharming Consumption Value (2018-2029) & (USD Million)
Figure 18. China Molecular Pharming Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Molecular Pharming Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Molecular Pharming Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Molecular Pharming Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Molecular Pharming Consumption Value (2018-2029) & (USD Million)
Figure 23. India Molecular Pharming Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Molecular Pharming by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Molecular Pharming Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Molecular Pharming Markets in 2022
Figure 27. United States VS China: Molecular Pharming Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Molecular Pharming Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Molecular Pharming Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Molecular Pharming Market Size Market Share by Type in 2022
Figure 31. Gene Gun
Figure 32. Agroinfiltration
Figure 33. Electroporation
Figure 34. Agrobacterium-Mediated Gene Transfer
Figure 35. World Molecular Pharming Market Size Market Share by Type (2018-2029)
Figure 36. World Molecular Pharming Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Molecular Pharming Market Size Market Share by Application in 2022
Figure 38. Recombinant Antibodies
Figure 39. Hormones, Vaccines
Figure 40. Industrial Enzymes
Figure 41. Proteins & Protein-Based Materials
Figure 42. Technical Reagents
Figure 43. Nutritional Products
Figure 44. Molecular Pharming Industrial Chain
Figure 45. Methodology
Figure 46. Research Process and Data Source
Figure 1. Molecular Pharming Picture
Figure 2. World Molecular Pharming Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Molecular Pharming Total Market Size (2018-2029) & (USD Million)
Figure 4. World Molecular Pharming Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Molecular Pharming Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Molecular Pharming Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Molecular Pharming Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Molecular Pharming Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Molecular Pharming Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Molecular Pharming Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Molecular Pharming Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Molecular Pharming Revenue (2018-2029) & (USD Million)
Figure 13. Molecular Pharming Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Molecular Pharming Consumption Value (2018-2029) & (USD Million)
Figure 16. World Molecular Pharming Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Molecular Pharming Consumption Value (2018-2029) & (USD Million)
Figure 18. China Molecular Pharming Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Molecular Pharming Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Molecular Pharming Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Molecular Pharming Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Molecular Pharming Consumption Value (2018-2029) & (USD Million)
Figure 23. India Molecular Pharming Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Molecular Pharming by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Molecular Pharming Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Molecular Pharming Markets in 2022
Figure 27. United States VS China: Molecular Pharming Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Molecular Pharming Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Molecular Pharming Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Molecular Pharming Market Size Market Share by Type in 2022
Figure 31. Gene Gun
Figure 32. Agroinfiltration
Figure 33. Electroporation
Figure 34. Agrobacterium-Mediated Gene Transfer
Figure 35. World Molecular Pharming Market Size Market Share by Type (2018-2029)
Figure 36. World Molecular Pharming Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Molecular Pharming Market Size Market Share by Application in 2022
Figure 38. Recombinant Antibodies
Figure 39. Hormones, Vaccines
Figure 40. Industrial Enzymes
Figure 41. Proteins & Protein-Based Materials
Figure 42. Technical Reagents
Figure 43. Nutritional Products
Figure 44. Molecular Pharming Industrial Chain
Figure 45. Methodology
Figure 46. Research Process and Data Source
